Badwelan M, et al. Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature. Curr Oncol. 2023;30(4):3721–34.

Article  PubMed  PubMed Central  Google Scholar 

Su KY, et al. Autophagy and extracellular vesicles mediate cisplatin resistance in oral squamous cell carcinoma with LC3B-II as a potential non-invasive biomarker. Sci Rep. 2025;15(1):15945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.

PubMed  Google Scholar 

Zhang X, et al. E3 ligase HERC5-catalyzed UGDH isgylation promotes SNAI1-mediated tumor metastasis and cisplatin resistance in oral squamous cell carcinoma. Biol Direct. 2025;20(1):27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, et al. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma. Microbiome. 2024;12(1):193.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Z, Wang X, Chen D. Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis. Exp Ther Med. 2023;25(5):224.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kulkarni B, et al. Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. Oncotarget. 2020;11(20):1832–45.

Article  PubMed  PubMed Central  Google Scholar 

Li C, Dong X, Li B. Tumor microenvironment in oral squamous cell carcinoma. Front Immunol. 2024;15:1485174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sasahira T, Kirita T. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(8):2413.

Warren I, et al. FOXA1/2 depletion drives global reprogramming of differentiation state and metabolism in a human liver cell line and inhibits differentiation of human stem cell-derived hepatic progenitor cells. FASEB J. 2023;37(1):e22652.

Article  CAS  PubMed  Google Scholar 

Yuan Z, et al. FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p/FOXA1/AGR2 Signaling Pathway. Onco Targets Ther. 2020;13:5231–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, et al. A novel mechanism in driving non-small cell lung cancer progression: The METTL3/FOXA1/PTK2 cascade. Mutat Res. 2025;831:111911.

CAS  PubMed  Google Scholar 

Pasterczyk KR, et al. Staufen1 Represses the FOXA1-Regulated Transcriptome by Destabilizing FOXA1 mRNA in Colorectal Cancer Cells. Mol Cell Biol. 2024;44(2):43–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, et al. FOXA1 Targets NEK2 to Mediate Cisplatin Resistance in Lung Adenocarcinoma Cells by Activating DNA Damage Repair. Drug Dev Res. 2025;86(2):e70087.

Article  CAS  PubMed  Google Scholar 

Bai J, Bai J, Zhang H. FOXA1-mediated transcription of MFAP2 facilitates cell growth, metastasis and cisplatin resistance in uterine corpus endometrial carcinoma. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(9):12421–31.

Article  CAS  PubMed  Google Scholar 

Liang Z, et al. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Cancer Biol Med. 2020;17(1):9–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, et al. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nie S, et al. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Exp Clin Cancer Res. 2021;40(1):284.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qu J, et al. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol. 2022;15(1):8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shriwas O et al. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG. Apoptosis. 2020;25(3–4):233–46.

Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7(11):847–59.

Article  CAS  PubMed  Google Scholar 

Qin Y, et al. Targeting the FOXA1/BMI1 axis to overcome chemoresistance and suppress tumor progression in nasopharyngeal carcinoma. Cell Death Discov. 2025;11(1):311.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Z et al. FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance. Anal Cell Pathol (Amst), 2022. 2022: p. 9675466.

Benayoun BA, Caburet S, Veitia RA. Forkhead transcription factors: key players in health and disease. Trends Genet. 2011;27(6):224–32.

Article  CAS  PubMed  Google Scholar 

Dalley AJ, et al. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy. J Oral Pathol Med. 2013;42(1):37–46.

Article  CAS  PubMed  Google Scholar 

Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608–24.

Article  CAS  PubMed  Google Scholar 

Liu Y, et al. Corrigendum to m6A-related genes ALKBH5 and RBMX as prognostic and progression biomarkers in Chinese oral squamous cell carcinoma patients [Archives of Oral Biology 170 (2024) 106149]. Arch Oral Biol. 2025;175:106230.

Article  PubMed  Google Scholar 

Drigeard Desgarnier MC, et al. The 6-methyladenine erasers ALKBH5 and FTO influence chemotherapy efficiency in bladder cancer cell lines. Ann Transl Med. 2025;13(3):26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu F et al. KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer. J Clin Invest. 2025;135(6):e185149.

Liu X, et al. M(6)A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer. Redox Biol. 2024;69:102993.

Article  CAS  PubMed  Google Scholar 

Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Du H, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.

Article  CAS  PubMed  PubMed Central  Google Scholar